Loading…
Longeveron Inc. is projected to decline to $0.6817 by 2027, a -7% move from its current price of $0.732. LGVN is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/4/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 5 | $0.7051 | $0.7315 | $0.759 | -0.06% |
| Aug 6 | $0.6939 | $0.7311 | $0.7702 | -0.13% |
| Aug 7 | $0.6854 | $0.7306 | $0.7788 | -0.19% |
| Aug 8 | $0.6783 | $0.7301 | $0.786 | -0.25% |
| Aug 9 | $0.672 | $0.7297 | $0.7924 | -0.32% |
| Aug 10 | $0.6663 | $0.7292 | $0.7981 | -0.38% |
| Aug 11 | $0.6611 | $0.7288 | $0.8034 | -0.44% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6611 | $0.7288 | $0.8034 | -0.44% |
| Week 2 | $0.6321 | $0.7255 | $0.8328 | -0.89% |
| Week 3 | $0.6101 | $0.7223 | $0.8552 | -1.33% |
| Week 4 | $0.5917 | $0.7191 | $0.8739 | -1.76% |
| Week 5 | $0.5757 | $0.7159 | $0.8903 | -2.20% |
| Week 6 | $0.5613 | $0.7127 | $0.905 | -2.63% |
| Week 7 | $0.5482 | $0.7096 | $0.9184 | -3.07% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Longeveron Inc. is a clinical stage biotechnology company that develops cellular therapies for aging-related and life-threatening conditions in the United States. It operates in the Healthcare sector and is focused on advancing its lead investigational product in clinical trials.
Its lead product, LOMECEL-B, is an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors, and it is in phase 3 to treat hypoplastic left heart syndrome. The company has completed a phase 2a clinical trial to treat Alzheimer's disease and is in phase 2b for aging frailty. Longeveron was incorporated in 2014 and is headquartered in Miami, Florida.
LGVN is a healthcare stock with a current price of $0.6753 and a market capitalization of $21.34M. It holds a rank of 4578 among listed assets. The stock sits within a framework of near-term neutrality but shows a long-run forecast that envisions higher prices in coming years.
The year-by-year outlook provides a path from stable levels in the mid-2020s to rising averages in the 2030s and beyond, with notable upside in the far term.
A major floor 34.3% below — a decisive break under it would weaken the trend.
The nearest floor, 18.7% below — buyers have tended to step in here.
The nearest ceiling, 12.0% above — a clean break opens room to run.
A major ceiling 58.5% above — clearing it would confirm fresh momentum.
Key LGVN support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of LGVN market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.6368 | Buy | $0.6521 | Buy |
| MA 10 | $0.6232 | Buy | $0.6382 | Buy |
| MA 20 | $0.6303 | Buy | $0.6475 | Buy |
| MA 50 | $0.7119 | Buy | $0.7008 | Buy |
| MA 100 | $0.828 | Sell | $0.7412 | Sell |
| MA 200 | $0.7282 | Buy | $0.861 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 57.34 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 216.00 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.01 | Buy |
| ROC (12) | 10.55 | Buy |
| Bollinger %B (20,2) | 1.14 | Sell |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.72 | Sell |
| Awesome (5,34) | -0.05 | Sell |
| Ultimate (7,14,28) | 65.99 | Neutral |
| Momentum (10) | 0.08 | Buy |
| Aroon Osc (25) | -76.00 | Sell |
| Hull MA (9) | 0.66 | Buy |
| ADX (14) | 22.63 | Buy |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is NEUTRAL. The RSI(14) is 50, and the price sits near key moving averages with the SMA50 at $0.7113 and the SMA200 at $0.7287. Immediate support is at $0.595 and resistance at $0.84. The 30-day range spans from $0.5293 to $0.8616, and annualized volatility is 70%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.484 | $0.732 | $0.9035 | 0% | Neutral | |
| $0.5266 | $0.6817 | $0.9427 | -7% | Neutral | |
| $0.5463 | $0.7358 | $1.07 | +1% | Neutral | |
| $0.5914 | $0.8235 | $1.24 | +12% | Neutral | |
| $0.6734 | $0.9655 | $1.50 | +32% | Bullish | |
| $0.6739 | $0.9927 | $1.59 | +36% | Bullish | |
| $0.6732 | $1.02 | $1.66 | +39% | Bullish | |
| $0.6389 | $0.9885 | $1.65 | +35% | Bullish | |
| $0.5701 | $0.9024 | $1.54 | +23% | Bullish | |
| $0.6703 | $1.08 | $1.88 | +48% | Bullish | |
| $0.7528 | $1.35 | $2.53 | +84% | Bullish | |
| $1.29 | $2.79 | $5.82 | +281% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $0.484 | $0.732 | $0.9095 | +0.00% |
| September 2026 | $0.6074 | $0.7254 | $0.8956 | -0.91% |
| October 2026 | $0.573 | $0.6908 | $0.8652 | -4.77% |
| November 2026 | $0.577 | $0.7009 | $0.8881 | +1.47% |
| December 2026 | $0.5768 | $0.7057 | $0.9035 | +0.68% |
Click any year to see its month-by-month LGVN forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Longeveron Inc.'s 2026 outlook centres on $0.732, within a $0.484 to $0.9035 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, LGVN could reach as high as $0.9427, with a base case around $0.6817 and support toward $0.5266 — roughly -7% from $0.732. A consolidation phase looks the most probable path here.
Expect LGVN to range from $0.5463 to $1.07 through 2028. The $0.7358 average target implies a +1% move from current prices. That is up +8% on the projected 2027 average. Price action looks broadly range-bound.
The LGVN price prediction for 2029 points to an average of $0.8235 (low $0.5914, high $1.24) — a potential gain of +12% on today's $0.732. A consolidation phase looks the most probable path here.
In 2030, LGVN is projected to trade between $0.6734 and $1.50, averaging $0.9655 — a potential gain of +32% from today's $0.732. That is up +17% on the projected 2029 average. Momentum favours further upside here.
Longeveron Inc.'s 2031 outlook centres on $0.9927, within a $0.6739 to $1.59 range. That is up +3% on the projected 2030 average. That marks a +36% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, LGVN could reach as high as $1.66, with a base case around $1.02 and support toward $0.6732 — roughly +39% from $0.732. Momentum favours further upside here.
Expect LGVN to range from $0.6389 to $1.65 through 2033. The $0.9885 average target implies a +35% move from current prices. That is -3% versus the projected 2032 average. Buyers look set to stay in control over this stretch.
The LGVN price prediction for 2034 points to an average of $0.9024 (low $0.5701, high $1.54) — a potential gain of +23% on today's $0.732. Momentum favours further upside here.
In 2035, LGVN is projected to trade between $0.6703 and $1.88, averaging $1.08 — a potential gain of +48% from today's $0.732. That is up +20% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Longeveron Inc.'s 2040 outlook centres on $1.35, within a $0.7528 to $2.53 range. That is up +24% on the projected 2035 average. That marks a +84% change versus current levels. Momentum favours further upside here.
By 2050, LGVN could reach as high as $5.82, with a base case around $2.79 and support toward $1.29 — roughly +281% from $0.732. Buyers look set to stay in control over this stretch.
Investing $1,000 in LGVN today (≈ 1,366.120219 LGVN) could be worth
$3,805.28
+$2,805.28 (+281%) by 2050 · US Dollar
Based on the average projected LGVN price of $2.79 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in LGVNwould be worth at today's price.
$1,000 invested in LGVN on Jul 31, 2025 (≈ 617.283949 LGVN) would be worth
$451.85
-$548.15 (-54.8%) today · 0.45× · US Dollar
Based on a LGVN entry price of $1.62 vs. today's $0.732.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.6 | $1,220 | +22.0% |
| 1 month ago | $0.729 | $1,004.12 | +0.4% |
| 3 months ago | $0.851 | $860.16 | -14.0% |
| 6 months ago | $0.536 | $1,365.67 | +36.6% |
| 1 year ago | $1.62 | $451.85 | -54.8% |
| All time (5.0y) ago | $58.9 | $12.43 | -98.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our LGVN forecast.
Our base-case forecast reaches $1.50 around 2050.
Implied market cap at $1.50: $45.22M
Looking across the multi-year forecast, the path shifts from modest near-term levels to clearer upside in the longer term. The 2026 forecast shows an average price of $0.6753 with a max of $0.8297 (ROI 0, sentiment NEUTRAL). By 2030, the average rises to $0.8654 with a min of $0.6029 and a max of $1.35, and ROI of 28.1% with a BULLISH tilt.
The 2040 projection shows an average of $1.20 and a max of $2.25 (ROI 77.7%, BULLISH), and by 2050 the forecast reaches an average of $2.44 with a max of $5.10 (ROI 260.9%, BULLISH). Key intermediate years such as 2031 (avg $0.9015, ROI 33.5%), 2032 (avg $0.9104, ROI 34.8%), and 2033 (avg $0.8824, ROI 30.7%) reinforce the overall bullish trajectory, while 2034 remains NEUTRAL with an average of $0.8102 and max $1.38 (ROI 20%). These figures illustrate a long-run upside potential, though they are estimates and not guaranteed, with risks inherent in early-stage biotechnology equities.
Tap a question to reveal the answer.
2030 forecast: avg $0.8654, min $0.6029, max $1.35, ROI 28.1%, sentiment BULLISH.
The forecast shows NEUTRAL sentiment in 2026 with avg $0.6753 and ROI 0, followed by a progression to BULLISH sentiment in 2030-2032 with higher avg prices and positive ROI (e.g., 2030 ROI 28.1%, 2031 ROI 33.5%, 2032 ROI 34.8%). Long-run outlook remains bullish in 2040 (ROI 77.7%) and 2050 (ROI 260.9%), but these are estimates, not guarantees.
Yes. The forecast maximums show $2.25 in 2040 and $5.10 in 2050, with an average around $1.20 in 2040 and $2.44 in 2050, indicating potential moves above $2 under the projected path.
Current price is $0.6753 and market cap is $21.34M.
Sentiment is NEUTRAL with RSI(14) at 50. SMA50 is $0.7113 and SMA200 is $0.7287. The 30-day range is $0.5293 to $0.8616, with support at $0.595 and resistance at $0.84; annualized volatility is 70%.
Longeveron Inc. Community Discussion
0Share your Longeveron Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.